Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (209)	11/22/1997 10:24:00 PM
From: 5,17,37,5,101,...	Read Replies (1) \| Respond to of 756

That blurb about Gabelli was old news from Barron's 7/97.... Q: What's your third $10 stock? Gabelli: IVAX Corp. There are 100-plus million shares. I went down to Florida and visited with them. [IVAX Chairman] Phil Frost terminated a deal with Bergen Brunswig, and the stock dropped to 7 or 8. They got hammered in the generic-drug business, lots of problems. But there is new management, not Phil. Phil remains the guiding light. They're refocusing. They're getting cash from the sale of a chemical business, so they're funding proprietary drugs. They are selling off--for $320 million, plus contingency payments of $80 million--a IV-solutions company called McGaw. Essentially, what I like is that they have wonderful R&D in proprietary drugs. They still have to sort out the generics. But if they make this work,you are going to make 50% on the stock, or more, in the next 12 months. It's a wonderful speculation at $10. The balance sheet, pro forma for the divestments, will look awfully good. I wonder if Mario is still bullish?